Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cytokinetics Inc (NASDAQ:CYTK)

During the Trading Day
7.00 +0.02 / +0.29%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
7.00 0.00 / 0.00%
Volume: 862.00
Health Technology

Company Description

Cytokinetics, Inc. is a clinical-stage biopharmaceutical company focused on the discovery and development of novel small molecule therapeutics that modulate muscle function for the potential treatment of serious diseases and medical conditions. Its current research and development programs relating to the biology of muscle function are directed to small molecule modulators of the contractility of cardiac, skeletal and smooth muscle. Cytokinetics was founded on August 5, 1997 and is headquartered in South San Francisco, CA.

Contact Information

Cytokinetics, Inc.
280 East Grand Avenue
South San Francisco California 94080
P:(650) 624-3000
Investor Relations:



Mutual fund holders--
Individual stakeholders--
Other institutional--

Top Executives

Robert I. BlumPresident, Chief Executive Officer & Director
Sharon A. BarbariChief Financial Officer, Secretary & Executive VP
Fady Ibraham MalikSenior Vice President-Research & Development
Andrew A. WolffChief Medical Officer & Senior Vice President
Bonnie A. CharpentierSenior VP-Regulatory Affairs & Compliance